A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a ...
GlaxoSmithKline has confirmed it will face a challenging 2019 as generics of its big-selling Advair drug finally reach the US, as it continues the transformation of its business. The FDA approved ...